UNSPSC 85742006: Revision of autologous tissue substitute in uterus and cervix, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in uterus and cervix, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0UWDX7Z

UNSPSC 85742006 Revision of autologous tissue substitute in uterus and cervix, external approach is a Commodity code that does not reflect actual state and local procurement activity. The recent opportunities tagged under this code span independent medical evaluation services for pension disability determinations, surgical carve-out benefit programs, occupational medical surveillance, juvenile detention health services, pharmacy benefit management, and temporary health professional staffing — none of which involve autologous tissue substitutes, uterine or cervical procedures, or related clinical interventions. The mismatch between the code's clinical specificity and the breadth of general health administration and staffing work appearing in the opportunities block suggests either systematic miscoding by issuing bodies or a data quality issue in the tagging process. This code shows little relevant recent activity aligned with its stated scope.

State and local procurement under this code, as currently tagged, involves health benefits administration, occupational health programs, and clinical staffing rather than specialized gynecological tissue procedures. No opportunities in the recent block solicite autologous tissue products or services. The issuing bodies span county health systems (Santa Clara), county pension boards (Maricopa County, Arizona), state transportation agencies (Washington State Department of Transportation), municipal governments (City of Long Beach, City of Phoenix), and county juvenile justice departments (Harris County), across Arizona, California, Florida, and Washington. Without opportunities genuinely addressing the code's clinical scope, pursuing activity under this classification presents minimal market signal or pipeline visibility.